The rights issue was subscribed with and without the support of unit rights to approximately 87.0 percent, and has in this part been allotted and registered with the Swedish Companies Registration Office. This means that the number of shares in Nanologica during October has increased by 38,423,596 shares from 44,178,618 to 82,602,214 shares and that the share capital has increased by SEK 3,842,359.6 from SEK 4,417,861.8 to SEK 8,260,221.4.
 
For the remaining approximately 13.0 percent of the rights issue, the underwriting commitment will be utilized. As a result of the regulations for insider trading, and in accordance with the decision on the rights issue, subscription and allotment of units covered by the underwriting commitment is expected to be completed during week 46. Thereafter, the part of the rights issue connected to the underwriting commitment will be registered with the Swedish Companies Registration Office.
 
The Extraordinary General Meeting on September 23, 2024, resolved to reduce the share capital by an amount in SEK corresponding to the amount by which the share capital increases through the rights issue (regarding the part where the share capital increase is attributable to a new issue of shares), with relevant adjustments to achieve an appropriate quota value. The company intends to carry out a reduction of the share capital either in connection with, or after, the last partial registration of the rights issue.
 
As of October 31, 2024, the last trading day of the month, the total number of shares and votes in Nanologica AB amounted to 82,602,214.